M. Badalamenti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
M. Badalamenti has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Davide Franceschini
Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, 20089 Milan, Italy
2 shared publications - Pietro Mancosu
Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
2 shared publications A. Bertolini
Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano - Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele - Milan, Italy
1 shared publication- Angelo Scuteri
University of Cagliari
1 shared publication C. Franzese
Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano - Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele - Milan, Italy
1 shared publicationC. Galdieri
IRCCS Humanitas Research Hospital, Department of Radiotherapy and Radiosurgery, Milan, Italy
1 shared publication
Latest Publications
- 19 May 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 197, 110335
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
- 19 May 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 197, 110335
Prospective phase II trial on ablative stereotactic body radiation therapy (SBRT) for medically inoperable thoracic nodes metastases
- 16 September 2023
- Published by Elsevier in Clinical Oncology
- Vol. 35 (12) , E649-E656
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival
- 16 September 2023
- Published by Elsevier in Clinical Oncology
- Vol. 35 (12) , E649-E656
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival